Evaluation Of Anemia After Long-Term Treatment With Imatinib In Chronic Myeloid Leukemia In Chronic Phase

被引:0
|
作者
Moura, Muriel Silva
Pagnano, Katia B.
Benevides, Thais
De Souza, Carmino A., Sr.
Lorand-Metze, Irene
Delamain, Marcia T.
Duarte, Gislaine O.
Pericole, Fernando V.
Percout, Priscila
Dias, Maria
Duarte, Bruno
Campos, Paula
Assuncao, Paola
Oliveira, Luciene
Paul, Pamela
Fernandes, Eliana
机构
关键词
D O I
10.1182/blood.V122.21.5200.5200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5200
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Frontline Treatment With Imatinib Mesylate in Chronic Myeloid Leukemia Patients in Early Chronic Phase: a Very Long-Term Analysis by the GIMEMA CML Working Party
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Breccia, Massimo
    Specchia, Giorgina
    Intermesoli, Tamara
    Capucci, Adele
    Martino, Bruno
    Tiribelli, Mario
    Binotto, Gianni
    Abruzzese, Elisabetta
    Stagno, Fabio
    Leoni, Pietro
    Ferrero, Dario
    Gherlinzoni, Filippo
    Palandri, Francesca
    Venturi, Claudia
    Bochicchio, Maria Teresa
    Soverini, Simona
    Alimena, Giuliana
    Martinelli, Giovanni
    Pane, Fabrizio
    Saglio, Giuseppe
    Cavo, Michele
    Baccarani, Michele
    Rosti, Gianantonio
    BLOOD, 2013, 122 (21)
  • [32] Imatinib for Chronic Myeloid Leukemia: The Impact of Its Effectiveness and Long-term Side Effects
    Smith, B. Douglas
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (07): : 527 - 529
  • [33] Karyotype changes during long-term targeted therapy of chronic myeloid leukemia with imatinib
    Pienkowska-Grela, Barbara
    Rygier, Jolanta
    Woroniecka, Renata
    Grygalewicz, Beata
    Pastwinska, Anna
    Krawczyk, Paulina
    Ceglerek, Bernadeta
    Seferynska, Ilona
    Sikorska, Anna
    Konopka, Lech
    LEUKEMIA & LYMPHOMA, 2009, 50 (06) : 952 - 965
  • [34] Long-term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patients
    Vinay, Keshavamurthy
    Yanamandra, Uday
    Dogra, Sunil
    Handa, Sanjeev
    Suri, Vikas
    Kumari, Savita
    Khadwal, Alka
    Prakash, Gaurav
    Lad, Deepesh
    Varma, Subhash
    Malhotra, Pankaj
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (03) : 332 - 338
  • [35] Treatment selection after imatinib resistance in chronic myeloid leukemia
    Elias Jabbour
    Jorge Cortes
    Hagop Kantarjian
    Targeted Oncology, 2009, 4 : 3 - 10
  • [36] Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia
    Cesini, Laura
    Frieri, Camilla
    Barate, Claudia
    Sora, Federica
    Bonifacio, Massimiliano
    Cerrano, Marco
    Cagnetta, Antonia
    Elena, Chiara
    Aprile, Lara
    Sgherza, Nicola
    Trawinska, Malgorzata
    Gozzini, Antonella
    Capodanno, Isabella
    Crugnola, Monica
    Carmosino, Ida
    Scalzulli, Emilia
    Ricci, Federica
    Bocchia, Monica
    Bergamaschi, Micaela
    Aguzzi, Chiara
    Sica, Simona
    Galimberti, Sara
    Breccia, Massimo
    Luciano, Luigiana
    Latagliata, Roberto
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (03) : 286 - 291
  • [37] Treatment selection after imatinib resistance in chronic myeloid leukemia
    Jabbour, Elias
    Cortes, Jorge
    Kantarjian, Hagop
    TARGETED ONCOLOGY, 2009, 4 (01) : 3 - 10
  • [38] PROJECTING THE LONG-TERM SURVIVAL OF NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE (CP) RECEIVING NILOTINIB OR IMATINIB
    Botteman, F.
    Stephens, J.
    Coombs, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 348 - 348
  • [39] Long-Term Prognostic Impact of the Use of Erythropoietic-Stimulating Agents in Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Imatinib
    Santos, Fabio P. S.
    Alvarado, Yesid
    Kantarjian, Hagop
    Verma, Dushyant
    O'Brien, Susan
    Mattiuzzi, Gloria
    Ravandi, Farhad
    Borthakur, Gautam
    Cortes, Jorge
    CANCER, 2011, 117 (05) : 982 - 991
  • [40] Long-Term Follow-up of Chronic Phase Chronic Myeloid Leukemia Patients Who Failed Interferon Alpha and Switched to Imatinib
    Breccia, Massimo
    Loglisci, Giuseppina
    Salaroli, Adriano
    Serrao, Alessandra
    Zacheo, Irene
    Latagliata, Roberto
    Alimena, Giuliana
    BLOOD, 2012, 120 (21)